Literature DB >> 27882505

Antitumor immunity and advances in cancer immunotherapy.

Tomoharu Sugie1, Masakazu Toi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27882505     DOI： 10.1007/s12282-016-0744-x

Source DB:  PubMed          Journal:  Breast Cancer        ISSN： 1340-6868            Impact factor:   4.239


× No keyword cloud information.
  4 in total

1.  Comparison of Direct and Indirect Methods of Teaching Breast Self-Examination – Influence on Knowledge and Attitudes of Iranian Nursing and Midwifery Personnel

Authors:  Sara Shahbazi; Mohammad Heidari; Mansour Ghafourifard
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

Review 2.  Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches.

Authors:  Nehad M Ayoub; Kamal M Al-Shami; Rami J Yaghan
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-01-17

Review 3.  HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development.

Authors:  Atefeh Arab; Rezvan Yazdian-Robati; Javad Behravan
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2020-01-09       Impact factor: 4.291

4.  B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer.

Authors:  Ling Wang; Fu-Biao Kang; Chao Yang; Xin-Bo Liu; Li Wang
Journal:  Cancer Cell Int       Date:  2018-07-13       Impact factor: 5.722
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.